Dasatinib, High-Dose Imatinib And Nilotinib In Chinese Patients With Chronic Phase Of Chronic Myeloid Leukemia With Imatinib-Resistance Or -Intoleran An Economic Evaluation
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1189
https://www.valueinhealthjournal.com/article/S1098-3015(15)03265-9/fulltext
Title :
Dasatinib, High-Dose Imatinib And Nilotinib In Chinese Patients With Chronic Phase Of Chronic Myeloid Leukemia With Imatinib-Resistance Or -Intoleran An Economic Evaluation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03265-9&doi=10.1016/j.jval.2015.09.1189
First page :
A460
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
688